Description
J. Joseph Melenhorst, PhD, Director of the Cell Therapy and Immuno-Engineering program and Vice Chair of the Center for Immunotherapy and Precision Immuno-Oncology, joins the Cancer Advances podcast to talk about the future of CAR T-Cell Therapy. Listen as Dr. Melenhorst discusses the progress being made, barriers to overcome, and and how we can improve cellular therapy to treat even more types of cancer.
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster